GlassScriptPhysician profile
Carah Whichard
NPI 1366058232
$2,338.81
in general payments reported to CMS, 2019-2025
19 companies · $723 in 2025
The $723 reported for 2025 was more than what 78% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $27.87 · 2022: $449 · 2023: $514 · 2024: $625 · 2025: $723.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,862.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,862.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $726.70 | 2023-2025 | Erleada, Carvykti, Rybrevant |
| Bayer Healthcare Pharmaceuticals INC. | $293.22 | 2022-2024 | |
| Sumitomo Pharma America, INC. | $255.69 | 2023-2025 | Orgovyx, Gemtesa |
| Myriad Genetic Laboratories, INC. | $185.97 | 2024 | Myrisk |
| Merck Sharp & Dohme LLC | $165.37 | 2021-2025 | Keytruda, Welireg |
| Boston Scientific Corporation | $134.73 | 2022 | |
| Myovant Sciences INC. | $127.19 | 2022 | |
| Progenics Pharmaceuticals, INC. | $99.48 | 2022 | |
| Ferring Pharmaceuticals INC. | $73.92 | 2024 | Adstiladrin |
| Dendreon Pharmaceuticals LLC | $39.85 | 2025 | Provenge |
| C. R. Bard, INC. & Subsidiaries | $35.70 | 2025 | Bard Urinary Drainage Bag |
| Astellas Pharma US INC | $32.87 | 2025 | Xtandi |
| Tempus Ai, INC | $31.60 | 2025 | Xt Cdx |
| Teleflex LLC | $31.02 | 2021-2022 | |
| Abbvie INC. | $26.78 | 2025 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $21.24 | 2025 | |
| Olympus America INC. | $19.82 | 2025 | Itind System |
| Tolmar, INC. | $19.00 | 2024 | |
| Pfizer INC. | $18.66 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carah Whichard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.